Immunosuppression management for refractory checkpoint inhibitor-related hepatotoxicity
Clin Liver Dis (Hoboken)
.
2024 Jan 19;23(1):e0096.
doi: 10.1097/CLD.0000000000000096.
eCollection 2024 Jan-Jun.
Authors
Gres Karim
1
,
Megha Reddy
2
,
Navim Mobin
1
,
Ilan Weisberg
1
,
Amreen Dinani
3
Affiliations
1
Division of Gastroenterology and Hepatology, New York Presbyterian-Brooklyn Methodist, Brooklyn, New York, USA.
2
Department of Internal Medicine, New York Presbyterian-Brooklyn Methodist, Brooklyn, New York, USA.
3
Division of Gastroenterology, Duke University Hospital, 40 Duke Medicine Cir, Durham, North Carolina, USA.
PMID:
38283303
PMCID:
PMC10810593
DOI:
10.1097/CLD.0000000000000096
No abstract available
Copyright © 2024 American Association for the Study of Liver Diseases.